Werewolf Therapeutics, Inc.
HOWL
$1.33
$0.053.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.25% | -11.71% | -69.96% | -101.24% | -238.35% |
| Total Depreciation and Amortization | -10.57% | -8.19% | -3.91% | 2.02% | 4.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.57% | -9.38% | 14.13% | -7.16% | -13.25% |
| Change in Net Operating Assets | -112.73% | -62.24% | -34.15% | 158.78% | 106.85% |
| Cash from Operations | -6.96% | -23.87% | -210.84% | -72.89% | -29.81% |
| Capital Expenditure | -- | -- | 37.88% | 98.64% | 90.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 37.88% | 98.64% | 90.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.29% | -- | -71.93% | -- | 37.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.99% | -- | -71.93% | -114.63% | -1,504.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.21% | -490.60% | -375.71% | -68.80% | -129.70% |